Astera Labs, Inc. Total Liabilities
Astera Labs, Inc. total liabilities. Based on the latest financial reports, Astera Labs, Inc. (ALAB) has total liabilities worth $205.80 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Astera Labs, Inc. (ALAB) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Astera Labs, Inc. (2022–2025)
Total liabilities of Astera Labs, Inc. from 2022 to 2025. This chart illustrates how Astera Labs, Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Astera Labs, Inc. Competitors by Total Liabilities
The table below lists competitors of Astera Labs, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Block, Inc
NYSE:XYZ
|
USA | $18.31 Billion |
|
Coherent Inc
NYSE:COHR
|
USA | $6.27 Trillion |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
USA | $1.83 Billion |
|
ASM INTL N.V. NY/1 EO-04
F:AVSN
|
Germany | €1.54 Billion |
|
WEG S.A.
SA:WEGE3
|
Brazil | R$26.48 Billion |
|
Ameriprise Financial Inc
NYSE:AMP
|
USA | $178.24 Billion |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
USA | $1.72 Billion |
|
LEGRAND UNSP.ARD 1/5 EO 4
F:LRC0
|
Germany | €10.42 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down Astera Labs, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Astera Labs, Inc..
Liquidity & Leverage Metrics
Astera Labs, Inc. Total Liabilities Ratios Explained
Astera Labs, Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Astera Labs, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Astera Labs, Inc. (2022–2025)
The table below shows the annual total liabilities of Astera Labs, Inc. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $168.19 Million | +87.48% |
| 2024-12-31 | $89.71 Million | +130.82% |
| 2023-12-31 | $38.87 Million | -86.91% |
| 2022-12-31 | $297.02 Million | -- |
About Astera Labs, Inc.
Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure in Taiwan and the United States. It offers an intelligent connectivity platform, comprised of semiconductor-based, high-speed, mixed-signal connectivity products that integrate a matrix of microcontrollers and sensors, and COSMOS. The company provides COSMOS software suite… Read more